BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 22587431)

  • 1. Can graphene oxide cause damage to eyesight?
    Yan L; Wang Y; Xu X; Zeng C; Hou J; Lin M; Xu J; Sun F; Huang X; Dai L; Lu F; Liu Y
    Chem Res Toxicol; 2012 Jun; 25(6):1265-70. PubMed ID: 22587431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro toxicity evaluation of graphene oxide on A549 cells.
    Chang Y; Yang ST; Liu JH; Dong E; Wang Y; Cao A; Liu Y; Wang H
    Toxicol Lett; 2011 Feb; 200(3):201-10. PubMed ID: 21130147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular biocompatibility evaluation of hydroxyl-functionalized graphene.
    Lin M; Zou R; Shi H; Yu S; Li X; Guo R; Yan L; Li G; Liu Y; Dai L
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():300-8. PubMed ID: 25746274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uniform ultrasmall graphene oxide nanosheets with low cytotoxicity and high cellular uptake.
    Zhang H; Peng C; Yang J; Lv M; Liu R; He D; Fan C; Huang Q
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1761-7. PubMed ID: 23402618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of PEGylated graphene oxide on lymphoma cells.
    Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y
    Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
    Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified graphene oxide dispersions lack in vitro cytotoxicity and in vivo pathogenicity.
    Ali-Boucetta H; Bitounis D; Raveendran-Nair R; Servant A; Van den Bossche J; Kostarelos K
    Adv Healthc Mater; 2013 Mar; 2(3):433-41. PubMed ID: 23184580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231).
    Gurunathan S; Han J; Park JH; Kim JH
    Int J Nanomedicine; 2014; 9():1783-97. PubMed ID: 24741313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic choline-like graphene oxide composites for neurite sprouting and outgrowth.
    Tu Q; Pang L; Wang L; Zhang Y; Zhang R; Wang J
    ACS Appl Mater Interfaces; 2013 Dec; 5(24):13188-97. PubMed ID: 24313218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line.
    Lv M; Zhang Y; Liang L; Wei M; Hu W; Li X; Huang Q
    Nanoscale; 2012 Jul; 4(13):3861-6. PubMed ID: 22653613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systems toxicology approach to the surface functionality control of graphene-cell interactions.
    Chatterjee N; Eom HJ; Choi J
    Biomaterials; 2014 Jan; 35(4):1109-27. PubMed ID: 24211078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes.
    An W; Zhang Y; Zhang X; Li K; Kang Y; Akhtar S; Sha X; Gao L
    Exp Eye Res; 2018 Sep; 174():59-69. PubMed ID: 29803558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphene oxide: a nonspecific enhancer of cellular growth.
    Ruiz ON; Fernando KA; Wang B; Brown NA; Luo PG; McNamara ND; Vangsness M; Sun YP; Bunker CE
    ACS Nano; 2011 Oct; 5(10):8100-7. PubMed ID: 21932790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein corona-mediated mitigation of cytotoxicity of graphene oxide.
    Hu W; Peng C; Lv M; Li X; Zhang Y; Chen N; Fan C; Huang Q
    ACS Nano; 2011 May; 5(5):3693-700. PubMed ID: 21500856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of graphene oxide on viability of Chinese hamster ovary and mouse hepatoma MH-22A cells.
    Batiuskaite D; Grinceviciute N; Snitka V
    Toxicol In Vitro; 2015 Aug; 29(5):1195-200. PubMed ID: 25982263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro study of single and four layer graphene oxide nanoflakes - Cytotoxicity and cellular uptake.
    Peruzynska M; Cendrowski K; Barylak M; Tkacz M; Piotrowska K; Kurzawski M; Mijowska E; Drozdzik M
    Toxicol In Vitro; 2017 Jun; 41():205-213. PubMed ID: 28323107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the toxicity of graphene oxide exposure to the eye.
    Wu W; Yan L; Wu Q; Li Y; Li Q; Chen S; Yang Y; Gu Z; Xu H; Yin ZQ
    Nanotoxicology; 2016 Nov; 10(9):1329-40. PubMed ID: 27385068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of graphene oxide on conformation change, aggregation and cytotoxicity of HIV-1 regulatory protein (Vpr).
    Zhang M; Mao X; Wang C; Zeng W; Zhang C; Li Z; Fang Y; Yang Y; Liang W; Wang C
    Biomaterials; 2013 Jan; 34(4):1383-90. PubMed ID: 23153418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.
    Xu M; Zhu J; Wang F; Xiong Y; Wu Y; Wang Q; Weng J; Zhang Z; Chen W; Liu S
    ACS Nano; 2016 Mar; 10(3):3267-81. PubMed ID: 26855010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells.
    Wang A; Pu K; Dong B; Liu Y; Zhang L; Zhang Z; Duan W; Zhu Y
    J Appl Toxicol; 2013 Oct; 33(10):1156-64. PubMed ID: 23775274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.